Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report

We have developed a therapeutic vaccine consisting of a mixture of lethally-irradiated allogeneic cutaneous melanoma cell lines with BCG and GM-CSF as adjuvants. The CSF-470 vaccine is currently being assayed in a Phase II-III trial against medium-dose IFN-a2b. All vaccinated patients immunized intr...

Full description

Bibliographic Details
Main Authors: Mariana eAris, Alicia Inés Bravo, María Marcela Barrio, José eMordoh
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00144/full